Renegade UxS ApS: Financial statements 2025
CVR: 44599570
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Renegade UxS ApS (CVR 44599570) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 85,302,269 and a net result of DKK 65,900,568 compared with DKK 3,363,829 the year before. That is an increase of 1,889.1% compared with the year before. Equity in the 2025 report amounted to DKK 68,004,397. The solvency ratio was 59.2%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 85,302,269
- Profit/Loss
- DKK 65,900,568
- Equity
- DKK 68,004,397
- Total Assets
- DKK 114,948,426
- Employees
- 2
Official annual report
How creditworthy is Renegade UxS ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Renegade UxS ApS has published its annual report for 2024. Gross profit came to DKK 4,288,569, and the net result was DKK 3,363,829.
About Renegade UxS ApS
Renegade UxS ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2024. The company is registered under the industry Fremstilling af civile luft- og rumfartøjer o.lign.. The company was previously named Remode Medical ApS. The management consists of Dennis Sobol Mikkelsen and Thomas Have. The company is owned by Tier One Nordic ApS. The company has 27 employees (2026). In 2025, the company reported a gross profit of DKK 85,302,269 and a net result of DKK 65,900,568 compared with DKK 3,363,829 the year before. Equity in the 2025 report amounted to DKK 68,004,397.